Jan 11 | Blogs
It’s only a few weeks in to the New Year and it’s sad to say that 2012 is already shaping up to be as bad as 2011 was in regards to pharmaceutical product recalls.
|
Dec 9 2011 | News
President Barack Obama said Thursday it was just common sense to keep girls under the age of 17 from being able to buy a morning-after contraceptive pill off a drugstore shelf.
|
Dec 7 2011 | News
An analysis published Tuesday in JAMA finds that androgen deprivation therapy (ADT) does not appear to raise the risk of death from cardiovascular causes.
|
Dec 2 2011 | News
Federal health officials are failing to monitor how state agencies are doling out powerful psychotropic drugs to foster children, according to a comprehensive investigation released Thursday showing foster kids are prescribed the drugs 2.7 to 4.5 times more than non-foster children and often at much higher doses.
|
Nov 23 2011 | News
Irish drugmaker Shire PLC has filed an application with U.S. and European regulators to produce its Gaucher disease drug at a new manufacturing site in Massachusetts, saying the move will give it flexibility to meet global demand for treatments of rare diseases.
|
Nov 23 2011 | News
The FDA issued a warning letter to Mylan for "significant violations" of manufacturing rules identified during a February inspection of a manufacturing plant in Caguas, Puerto Rico.
|
Nov 18 2011 | News
The state of Vermont is going to have to pay $1.8 million in legal expenses incurred by an opponent in a losing legal battle over access to information about what drugs doctors prescribe their patients.
|
Nov 17 2011 | News
A South African pharmaceutical manufacturer is fighting moves toward banning a painkiller that has been removed from the shelves in the U.S. and Europe because of fears it could harm the heart.
|
Sep 14 2011 | News
The U.S. FDA announced today that two Minnesota companies have agreed to halt distribution of amino-acid products marketed to treat a number of diseases, until requirements of the Federal Food, Drug, and Cosmetic Act are met.
|
Aug 9 2011 | News
Merck & Co. disclosed Monday in an SEC filing that it received a
subpoena from the U.S. Department of Justice as part of a "federal health
care investigation under criminal statutes" into the company’s marketing
of three drugs acquired in its merger with Schering-Plough.
|